|
|
|
|
| LEADER |
01232naa a2200289 i 4500 |
| 001 |
NSK01001064807 |
| 003 |
HR-ZaNSK |
| 005 |
20200601153123.0 |
| 007 |
ta |
| 008 |
200601s2017 ci | |0|| ||hrv |
| 035 |
|
|
|a (HR-ZaNSK)001064807
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a hrv
|b eng
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 616
|2 2011
|
| 100 |
1 |
|
|a Juretić, Antonio
|4 aut
|
| 245 |
1 |
0 |
|a Klinička imunoterapija raka blokadom molekularnih interakcija negativne povratne sprege =
|b Tumor immunotherapy in clinical setting based on the blockade of molecular interactions of the negative feedback mechanism /
|c Antonio Juretić, Martina Bašić-Koretić.
|
| 246 |
3 |
1 |
|a Tumor immunotherapy in clinical setting based on the blockade of molecular interactions of the negative feedback mechanism
|
| 504 |
|
|
|a Bibliografija: 33 jed.
|
| 504 |
|
|
|a Summary
|
| 653 |
|
0 |
|a Tumori
|a Imunologija
|a Klinički imunologija
|a Molekularna interakcija
|
| 700 |
1 |
|
|a Bašić-Koretić, Martina
|4 aut
|
| 773 |
0 |
|
|t Liječnički vjesnik
|x 0024-3477
|g 139 (2017), 5/6 ; str. 168-172
|w nsk.(HR-ZaNSK)000005727
|
| 981 |
|
|
|b B13/17
|
| 998 |
|
|
|b gtao2006
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/187276
|y Elektronička verzija članka
|